GW Cancer Center

Rohan Fernandes, PhD, received more than $1.6 million from the National Institutes of Health to investigate nanoimmunotherapies for cancer

Members of the GW Cancer Center recently published several journal articles and patient-focused pieces highlighting the Center’s work in patient navigation and survivorship.

The GW Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS, an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center. He will serve as the director of the recently established Cutaneous Oncology Program.

A paper Oncology Issues journal paper, published by Adam Friedman, MD, director of translational research in the Department of Dermatology at SMHS, and MD student Stephanie Kao, is part of an effort to raise awareness of supportive oncodermatology.

A host of representatives from throughout the George Washington University (GW) health care community joined GW Cancer Center leadership on Oct.

Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.

Catherine Bollard, MD, associate center director for translational research and innovation at GW Cancer Center, was quoted by Interesting Engineering in an article about her recent study looking at the safety of a cell therapy involving expanding T-cells against HIV.

Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.

A team at the GW Cancer Center will study the role of the COMPASS complex in the initiation and progression of pancreatic cancer.

The GW Cancer Center is pleased to welcome a team of internationally-recognized experts who together will lead the expanded Bone Marrow Transplant and Cell Therapies Program.